Stay updated on FT538 with Daratumumab in AML Clinical Trial

Sign up to get notified when there's something new on the FT538 with Daratumumab in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the FT538 with Daratumumab in AML Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The site revision label changes from v3.8.0 to v3.8.1, with no change to the study record content.
    Difference
    0.1%
    Check dated 2026-11-18T01:15:59.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The site footer now identifies the ClinicalTrials.gov release as v3.8.0 instead of v3.7.2.
    Difference
    0.1%
    Check dated 2026-11-03T21:20:08.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    An NIH-wide notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears, and the site revision changes from v3.7.1 to v3.7.2.
    Difference
    0.8%
    Check dated 2026-10-20T21:37:44.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-06T20:44:41.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The record history now includes a new revision entry for v3.7.0 and removes the v3.6.6 entry, updating the version history shown on the page.
    Difference
    0.1%
    Check dated 2026-09-15T20:41:06.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    A new revision entry v3.6.6 is added to the study's history and the previous revision v3.6.5 is removed. This reflects an update to the page's version history rather than substantive changes to study data or content.
    Difference
    0.1%
    Check dated 2026-09-01T18:29:44.000Z thumbnail image

Stay in the know with updates to FT538 with Daratumumab in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the FT538 with Daratumumab in AML Clinical Trial page.